Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin

American Journal of Surgical Pathology

Volumn 31, Issue 2, 2007, Pages 304-310

  Liang, Haohai ^a   Wu, Hong ^b   Giorgadze, Tamar A ^c   Sariya, Dinesh ^b   Bellucci, Kirsten S W ^a   Veerappan, Ranjitha ^c   Liegl, Bernadette ^e   Acs, Geza ^a   Elenitsas, Rosalie ^a   Shukla, Shruti ^c   Youngberg, George A ^d   Coogan, Philip S ^c   Pasha, Theresa ^a   Zhang, Paul J ^a   Xu, Xiaowei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c East Tennessee State University   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adnexal carcinoma; Metastatic adenocarcinoma; Podoplanin

Indexed keywords

BIOLOGICAL MARKER; D2 40 ANTIBODY; MONOCLONAL ANTIBODY; PODOPLANIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; POROCARCINOMA; SEBACEOUS CARCINOMA; SKIN ADNEXAL CANCER; SKIN CARCINOMA; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; PREDICTIVE VALUE OF TESTS; SEBACEOUS GLAND NEOPLASMS; SINGLE-BLIND METHOD; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846604255     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213388.47913.f1     Document Type: Article

References (30)

1. Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer. 1972;29:1298-1307.
2. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms. An immunohistochemical study of 509 cases. Mod Pathol. 2002;15:6-10.
3. Chu AY, Litzky LA, Pasha TL, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol. 2005;18:105-110.
4. Cotsarelis G, Cheng SZ, Dong G, et al. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989; 57:201-209.
5. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61: 1329-1337.
6. Cury PM, Butcher DN, Fisher C, et al. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol. 2000; 13:107-112.
7. Debelenko LV, Perez-Atayde AR, Mulliken JB, et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol. 2005;18:1454-1460.
8. Dumoff KL, Chu CS, Harris E, et al. Low expression of podoplanin in pretreatment biopsy material predicts poor outcome in advanced stage squamous cell carcinoma of the cervix treated with primary radiation. Mod Pathol. 2006;19: 708-716.
9. Dumoff KL, Chu C, Xu X, et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol. 2005;18:97-104.
10. Fogt F, Zimmerman RL, Ross HM, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep. 2004; 11:47-50.
11. Franchi A, Gallo O, Massi D, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer. 2004;101:973-978.
12. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005; 46:396-402.
13. Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol. 2005;8:181-189.
14. Giorgadze TA, Zhang PJ, Pasha T, et al. Lymphatic vessel density is significantly increased in melanoma. J Cutan Pathol. 2004; 31:672-677.
15. Gombos Z, Xu X, Chu CS, et al. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor-C expression in early stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res. 2005;11: 8364-8371.
16. Healey PM, Malott K, Chalet MD. Cancers metastatic to the skin. In: Friedman RJ, Rigel DS, Harris MN, et al, eds. Cancer of the Skin. Philadelphia, PA: WB Saunders; 1991:347-363.
17. Hirakawa S, Hong YK, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol. 2003; 162:575-586.
18. Hong YK, Harvey N, Noh YH, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn. 2002;225:351-357.
19. Jih DM, Lyle S, Elenitsas R, et al. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol. 1999;26:113-118.
20. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15: 434-440.
21. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
22. Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96:164-167.
23. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer. 1999;80: 569-578.
24. Niakosari F, Kahn HJ, Marks A, et al. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol. 2005;141:440-444.
25. Ordonez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelioid mesothilioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215-1221.
26. Ordonez NG. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol. 2005;36:372-380.
27. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK7, and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31:145-152.
28. Roy S, Chu A, Trojanowski JQ, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol (Berl). 2005;109:497-502.
29. Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913-921.
30. Taylor G, Lehrer MS, Jensen PJ, et al. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:451-461.